
CAS 1849590-01-7
:Formel:C17H20N6O2
InChl:InChI=1S/C17H20N6O2/c1-10-7-11(21-13-8-12(18)19-9-20-13)16(25)23-14(10)15(24)22-17(23)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H3,18,19,20,21)
InChI Key:HKTBYUWLRDZAJK-UHFFFAOYSA-N
SMILES:CC1=C2C(=O)NC3(N2C(=O)C(=C1)NC4=NC=NC(=C4)N)CCCCC3
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione
CAS:Formel:C17H20N6O2Reinheit:98%Farbe und Form:SolidMolekulargewicht:340.3797Ref: IN-DA00ABRG
1mg65,00€5mg65,00€10mg106,00€25mg165,00€50mg220,00€100mg350,00€250mg668,00€1g1.573,00€6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione
CAS:Kontrolliertes ProduktApplications 6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione was used in the study of inhibitors of immune checkpoint modulators and related methods. eFT508 is a potent, highly selective, and orally bioavailable MNK1 and MNK2 inhibitor.
References Webster, K., et al.: U.S. Pat. Appl. Publ. (2016), US 20160303124 A1 20161020; Webster, K., et al.: Blood, 126, 1554 (2015);Formel:C17H20N6O2Farbe und Form:NeatMolekulargewicht:340.38eFT508
CAS:eFT508Formel:C17H20N6O2Reinheit:98.8% (Typical Value in Batch COA)Farbe und Form:SolidMolekulargewicht:340.37969Tomivosertib
CAS:6'-((6-Aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dioneFormel:C17H20N6O2Reinheit:98%Molekulargewicht:340.38Tomivosertib
CAS:Tomivosertib (eFT508) is a potent, highly selective MNK1 and MNK2 inhibitor with IC50 value of 1-2 nM.Formel:C17H20N6O2Reinheit:98.42% - 99.72%Farbe und Form:SolidMolekulargewicht:340.3797eFT 508
CAS:Dual inhibitor of MNK1/2 (regulators of mRNA translation)Formel:C17H20N6O2Reinheit:Min. 95%Molekulargewicht:340.38 g/mol





